Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MPM BioImpact, formerly known as MPM Capital, is a prominent biotechnology investment firm with over three decades of experience in founding and investing in companies that develop transformative therapies. The firm operates across the full spectrum of biotechnology investing, including venture capital funds and public equity strategies. MPM is particularly recognized for its company creation model, where it actively collaborates with scientists and entrepreneurs to build startups from the ground up, primarily focusing on oncology and other areas of significant unmet medical need. With a deep bench of investment professionals and executive partners, the firm has been instrumental in the development of numerous successful biotech companies that have achieved significant clinical and commercial milestones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MPM Capital Advisors.